*This is a Global Results Framework Indicator.
Result Statement: Increased % of children having minimum reading and maths proficiency by Grade 2
Use Early Grade Reading Assessment (EGRA) to collect data for this indicator. EGRA is an internationally recognized RTI/USAID-developed tool for measuring reading skills in young students:
> EGRA is a brief but thorough oral assessment administered individually to randomly selected students that accurately evaluates students’ knowledge of foundational reading.
> The assessment is used during the baseline stage of a programme for assessing foundational reading levels of children. This provides a measure of how many children are reading at the appropriate grade level. The same test is administered at the end (final evaluation) to assess the impact of the programme. Students tested at the onset of an intervention and subsequent to the instructional intervention would be expected to demonstrate improvement over time.
> At each testing, the assessment is undertaken with a sample of children currently at the end of Grade 2 (or early Grade 3) – not with the same children.
> The tool is administered, by a trained enumerator, to each child individually. It takes about 10 minutes to complete. The details of the procedure and the forms can be found in EGRA Field Guide. The benchmark of how many words a student needs to read within 60 seconds has to be set depending on the given language, because orthographies and other factors influence the rate of fluency acquisition - do not automatically use the 45 words per minute standard provided in the Field Guide. For more guidance on setting the benchmark, read EGRA Benchmarks and Standards Research Report (see below).
> Sample size and selection: To obtain representative data for your target school, you will need to randomly select students to take part in the assessment. Read the details on sampling in EGRA Field Guide and consult your Education and/or M&E Advisor.
> The enumerators can either record the results on paper forms or electronically in tablets.